Fostering Global Networking
for Better Prevention and Care of Atherosclerosis
- Laicon International Conference 2022, New Delhi, India, August 13-14, 2022.
- Ms. Razan Al-Zadjali (Muscat, Oman) is one of the three winners of the 3rd Wael Al-Mahmeed & IAS Research Training Grants 2021 – Final Report of the Research/Training.
- Laicon National Conference 2022, Mumbai, India, April 23-24, 2022.
- The IAS has released a new video series, Severe Dyslipidemias in LATAM: Confronting the Future, in the IAS Education Center (IASEC).
- World Heart Federation Statement on Ukraine
- The Japan Atherosclerosis Society recently published a new paper: The Japan Diet: Diet for the Prevention of ASCVD
Prof. Peter Libby
President of the International Atherosclerosis Society
I write to share exciting news about the future of the International Atherosclerosis Society. On April 1st, our long time Executive Director Emanuela Folco assumed a new role as the Society’s Executive Vice President. In this capacity, she will serve as a key interface between the member societies and the Board of Directors. Emanuela remains a critical part of IAS’ leadership team and will work with Jasmine Patel who has agreed to serve as the new IAS Executive Director. Emanuela’s commitment to IAS and her institutional knowledge will continue to benefit the Society, and in this new role, she will be an invaluable resource as we pass the torch to a new executive director. We owe Emanuela deep gratitude for the decades of devoted service to IAS that have advanced our Society’s missions immeasurably.
Jasmine Patel has worked with IAS for the past several months as part of the Society’s management firm, Woodberry Associates. Jasmine’s relationship with IAS dates back several years to her time with the FH Foundation in the United States. There she served as a trusted program collaborator with the IAS including in developing the Global Call to Action on Familial Hypercholesterolemia. Jasmine is a proven leader who has the professional experience and familiarity with our field to help guide IAS to new heights.
With Emanuela and Jasmine joining forces, I am confident that IAS will succeed in reaching its objective to develop programming that furthers the Society’s mission and benefit its members. In 2022 and beyond, IAS will be active in all regions with programming that advances advocacy, education, diversity, empowerment, and research. We do so in our mutual quest to advance understanding of the etiology, prevention and treatment of atherosclerosis and its risk factors including diabetes and cardiometabolic disorders.
The IAS e-Newsletter is a monthly digest of the latest from the IAS and our Constituent Member Societies.
Going well beyond “Statins,” this resource is a clinical tool on the latest information confronting clinicians and researchers.
This members-only newsletter provides an update on new lipid lowering drugs.